We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ARAB HEALTH - INFORMA

BIOSYNEX

Biosynex designs, manufactures and distributes Rapid Diagnostic Tests (RDTs) which, in their professional version, al... read more Featured Products: More products

Download Mobile App




Pocket Laboratory Offers Fast and Reliable Diagnosis at Point of Care

By HospiMedica International staff writers
Posted on 10 Apr 2023
Print article
Image: LabPad Evolution is a handheld PoC multi-measurements testing device (Photo courtesy of Biosynex)
Image: LabPad Evolution is a handheld PoC multi-measurements testing device (Photo courtesy of Biosynex)

A multi-technology, multi-parameters Point of Care (PoC) device combines two technologies in a single device for a unique evolutive panel of tests. The pocket-sized lab can perform multiple biological analyses from just a finger prick of blood and send the results via Bluetooth to a smartphone or tablet.

LabPad Evolution from Biosynex SA (Illkirch-Graffenstaden, France) is a handheld PoC device that healthcare professionals can use to perform multiple lab-quality measurements directly with patients. With its miniature automated microscope built from two CMOS sensors, the LabPad Evolution can carry out blood tests from a single finger prick. The device uses compatible single-use SmartChip tests that are available in two formats: Tsmart and Ksmart, each for different types of testing. Tsmart is intended for coagulation testing as INR, consisting of a microfluidic microcuvette embedding a dried or freeze-dried reagent (dry chemistry) while Ksmart is meant for lateral flow testing based on visual or fluorescent optical measurements. The LabPad Evolution automatically conducts internal quality controls before, during, and after each measurement, and displays an error message if any interference is detected.

LabPad Evolution can operate as a standalone tool, storing up to 1,000 results in its memory, which can be viewed on its screen. Additionally, the LabPad Evolution is fully connected and can transmit results automatically via USB or Bluetooth. It can integrate with information systems for centralized processes such as operator authorization/identification, patient identification, quality controls, and results validation/management. The current available SmartChip tests are for SARS-COV-2 Antigen, SARS-COV-2 Antibody, and TP/INR rapid tests. Future tests will focus on nutrition and cardiac markers.

Related Links:
Biosynex SA

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Cannulating Sphincterotome
TRUEtome
New
5-Drawer Tall Anesthesia Cart
UTGKU-33669-DKB

Print article

Channels

Critical Care

view channel
Image: The study used a new electronic diagnostic model as an alternative to kidney biopsies to predict AIN (Photo courtesy of 123RF)

Electronic Diagnostic Model Predicts Acute Interstitial Nephritis in Patients

Acute interstitial nephritis (AIN) is a frequent cause of acute kidney injury (AKI), characterized by inflammation and swelling of certain kidney tissues. It is typically associated with the use of medications... Read more

Surgical Techniques

view channel
Image: A wireless, fully implantable LVAD system could reduce the risk of infections and complications (Photo courtesy of 123RF)

Wireless, Fully Implantable LVAD System to Make Life Easier for Heart Failure Patients

Left Ventricular Assist Devices (LVADs) have traditionally relied on physical drivelines to provide power, creating a connection through the patient's skin. These drivelines increase the risk of infections... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.